|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-8-10
|
|
pubmed:abstractText |
A 15-fold increased risk of gastrointestinal bleeding has been reported with concurrent use of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs. Recent guidance cautions against concurrent prescription, particularly in older people.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
175-81
|
|
pubmed:meshHeading |
pubmed-meshheading:16091054-Adult,
pubmed-meshheading:16091054-Aged,
pubmed-meshheading:16091054-Aged, 80 and over,
pubmed-meshheading:16091054-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:16091054-Antidepressive Agents, Second-Generation,
pubmed-meshheading:16091054-Case-Control Studies,
pubmed-meshheading:16091054-Comorbidity,
pubmed-meshheading:16091054-Drug Interactions,
pubmed-meshheading:16091054-England,
pubmed-meshheading:16091054-Female,
pubmed-meshheading:16091054-Gastrointestinal Hemorrhage,
pubmed-meshheading:16091054-Humans,
pubmed-meshheading:16091054-Male,
pubmed-meshheading:16091054-Middle Aged,
pubmed-meshheading:16091054-Polypharmacy,
pubmed-meshheading:16091054-Serotonin Uptake Inhibitors,
pubmed-meshheading:16091054-Smoking,
pubmed-meshheading:16091054-Wales
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?
|
|
pubmed:affiliation |
Epidemiology and Public Health, University of Nottingham, City Hospital, Nottingham, UK. laila.tata@nottingham.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|
